跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lipoprotein(a)
首页
药物
Lipoprotein(a)
Lipoprotein(a)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
A RECONSTITUTED HIGH DENSITY LIPOPROTEIN FORMULATION AND PRODUCTION METHOD THEROF
EP 3492085 A1
申请人: CSL LTD
优先权: 2010
EP
US
7 件公开
METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
EP 4461373 A3
申请人: REGENERON PHARMA
优先权: 2011
CN
EP
US
6 件公开
Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases
US 7244749 B2
申请人: RATH MATTHIAS
优先权: 2000
CN
US
5 件公开
Method of inhibiting remnant lipoprotein production
EP 2316447 A1
申请人: JAPAN TOBACCO INC
优先权: 2004
EP
US
5 件公开
Immunological combination compositions and methods
US 6984385 B2
申请人: CONNAUGHT LAB
优先权: 2002
US
5 件公开
CHOLESTEROL-FREE HIGH-DENSITY LIPOPROTEIN PARTICLES
EP 4414379 A4
申请人: PHOENIXBIO CO LTD
优先权: 2021
CN
EP
US
WO
4 件公开
Glycan modified soluble receptors and binding protein and their use
US 8871723 B2
申请人: RUBINSTEIN MENACHEM
优先权: 2007
EP
US
WO
4 件公开
LOW-DENSITY LIPOPROTEIN RECEPTOR 6 (LRP6) AS A MAMMARY STEM CELL MARKER AND RELATED METHODS
US 2007292348 A1
申请人: WILLIAMS BART O
优先权: 2007
US
4 件公开
Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations
US 2005276813 A1
申请人: MUHLRADT PETER
优先权: 2002
EP
US
3 件公开
Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
US 9446013 B2
申请人: FRAMROZE BOMI PATEL
优先权: 2009
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈